Intratumor heterogeneity: Nature and biological significance
- 14 November 2013
- journal article
- review article
- Published by Pleiades Publishing Ltd in Biochemistry (Moscow)
- Vol. 78 (11), 1201-1215
- https://doi.org/10.1134/s0006297913110011
Abstract
Intratumor heterogeneity inherent in the majority of human cancers is a major obstacle for a highly efficient diagnosis and successful prognosis and treatment of these diseases. Being a result of clonal diversity within the same tumor, intratumor heterogeneity can be manifested in variability of genetic and epigenetic status, gene and protein expression, morphological structure, and other features of the tumor. It is most likely that the appearance of this diversity is a source for the adaptation of the tumor to changes in microenvironmental conditions and/or a tool for changing its malignant potential. In any case, both processes result in the appearance of cell clones with different undetermined sets of hallmarks. In this review, we describe the heterogeneity of molecular disorders in various human tumors and consider modern viewpoints of its development including genetic and non-genetic factors of heterogeneity origin and the role of cancer stem cells and clonal evolution. We also systematize data on the contribution of tumor diversity to progression of various tumors and the efficiency of their treatment. The main problems are indicated in the diagnosis and therapy of malignant tumors caused by intratumor heterogeneity and possible pathways for their solution. Moreover, we also suggest the key goals whose achievement promises to minimize the problem of intratumor heterogeneity and to identify new prognostic, predictive, and target markers for adequate and effective treatment of cancer.Keywords
This publication has 98 references indexed in Scilit:
- Cancer heterogeneity: implications for targeted therapeuticsBritish Journal of Cancer, 2013
- Intratumoral Heterogeneity as a Therapy Resistance MechanismPublished by Elsevier BV ,2012
- A restricted cell population propagates glioblastoma growth after chemotherapyNature, 2012
- Intratumoral Heterogeneity of MicroRNA Expression in Breast CancerThe Journal of Molecular Diagnostics, 2012
- Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectivesEMBO Molecular Medicine, 2012
- Mutational Processes Molding the Genomes of 21 Breast CancersCell, 2012
- The Life History of 21 Breast CancersCell, 2012
- Mouse models of cancers: opportunities to address heterogeneity of human cancer and evaluate therapeutic strategiesJournal of Molecular Medicine, 2010
- Complex landscapes of somatic rearrangement in human breast cancer genomesNature, 2009
- Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancerNature Genetics, 2005